Nanosonics

Nanosonics FCF Margin

The Free Cash Flow Margin of Nanosonics (NAN.AX) as of Oct 28, 2026 is 8.56 %. In the previous year, Free Cash Flow Margin was 17.72 % — a change of -51.71% (lower).

FCF Margin

8.56 %

YoY

-51.71%

Last updated:

Free Cash Flow Margin of Nanosonics is 2026 8.56 % . Free Cash Flow Margin of Nanosonics was 2025 17.72 % . It decreases by -51.71% lower compared to the previous year.

The Nanosonics FCF Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Margin
Date
FCF Margin
Jan 1, 2019
3.73 AUD
Jan 1, 2020
20.96 AUD
Jan 1, 2021
5.83 AUD
Jan 1, 2022
-0.23 AUD
Jan 1, 2023
11.79 AUD
Jan 1, 2024
11.81 AUD
Jan 1, 2025
17.72 AUD
Jan 1, 2026
8.56 AUD
The Nanosonics FCF Margin history
YEARFCF MarginYoY
8.56 %-51.71%
17.72 %+50.06%
11.81 %+0.22%
11.79 %-5,306.98%
-0.23 %-103.88%
5.83 %-72.20%
20.96 %+462.45%
3.73 %-66.22%
11.03 %-51.41%
22.70 %+354.56%
4.99 %-124.35%
-20.51 %+45.62%
-14.08 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nanosonics Stock analysis

What does Nanosonics do? Nanosonics Ltd is an Australian company specializing in the development of innovative disinfectants designed specifically for use in medical facilities. The company was founded in 2000 by two scientists, Ron Weinberger and Kelvin Trautman, with the aim of reducing the spread of infections through medical devices and equipment. Nanosonics developed a new disinfectant based on the use of ultrasound to achieve higher effectiveness. Its first product, the Trophon EPR, was launched in 2007 and was the world's first Dry Chemical Disinfection system specifically designed for ultrasound probes. Nanosonics has since expanded its product line to include the Trophon2, an improved version of the Trophon EPR, and Ultra, a hand sanitizer for use in medical facilities. It has also developed the TRISTEL Duo disinfection system for flexible endoscopes. Nanosonics is focused on sustainable growth and works closely with customers to develop products tailored to their specific needs. The company is headquartered in Sydney, Australia, with branches in Europe and North America to support global expansion. Technological innovation and collaboration with customers have helped Nanosonics establish itself as a leading provider of disinfection solutions for medical facilities, ensuring patient safety and infection control. Nanosonics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nanosonics stock

Free Cash Flow Margin of Nanosonics is 8.56 % in 2026.

Free Cash Flow Margin of Nanosonics changed from 17.72 % to 8.56 %, representing a -51.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow Margin Nanosonics since 2006 – with annual values, charts, and detailed analysis.

FCF Margin measures the percentage of revenue converted to free cash flow. It indicates how efficiently a company generates cash from its operations.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow Margin's Nanosonics with sector peers and the industry average to assess whether it is attractive.

To evaluate Free Cash Flow Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Free Cash Flow Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Nanosonics

All Key Metrics — Nanosonics